-
GoDaddy To Rally Around 44%? Here Are 10 Other Analyst Forecasts For Wednesday
Wednesday, September 13, 2023 - 8:45am | 566Needham cut the price target for Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) from $60 to $53. Needham analyst Gil Blum maintained a Buy rating. Rocket Pharmaceuticals shares rose 24.3% to $19.00 in pre-market trading. Goldman Sachs slashed Ultrapar Participações S.A. (NYSE: UGP)...
-
What's Going On With Neurocrine Biosciences Stock Today?
Tuesday, September 12, 2023 - 2:33pm | 295Neurocrine Biosciences Inc (NASDAQ: NBIX) announced positive topline data from the Phase 3 CAHtalyst Adult Study evaluating crinecerfont in adults with classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency (21-OHD). CAH is a group of genetic conditions limiting...
-
QUALCOMM, McKesson And 2 Other Stocks Insiders Are Selling
Tuesday, September 12, 2023 - 12:44pm | 649The Nasdaq 100 closed higher by over 1% on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders sell shares, it could be a preplanned sale, or could indicate their concern in the company’s prospects or that they view the stock as being overpriced. Insider sales...
-
Why LeMaitre Vascular Is A Market Leader In Core Segments: Oppenheimer Initiates With Outperform Rating
Wednesday, September 6, 2023 - 3:04pm | 264Oppenheimer has initiated coverage on LeMaitre Vascular Inc (NASDAQ: LMAT) with an Outperform rating and a price target of $70. Analysts Suraj Kalia and Shaymus Contorno note that approximately 90% of current sales are generated from ~1/3rd of its core markets, including ePTFE...
-
Why Lands' End Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Thursday, August 31, 2023 - 12:50pm | 1566Gainers Acer Therapeutics Inc. (NASDAQ: ACER) shares jumped 145% to $1.4850 after Zevra Therapeutics announced it will acquire the company. The transaction will have a total potential value for Acer stockholders of up to $91 million. 1847 Holdings LLC (NASDAQ: EFSH) surged 66.6% to $0.17. 1847...
-
Why MACOM Technology Is A 'Buy': Analyst Upgrades MTSI With $92 Price Target Post-Wolfspeed Acquisition
Monday, August 28, 2023 - 2:13pm | 300Benchmark analyst David Williams upgraded MACOM Technology Solutions Holdings Inc. (NASDAQ: MTSI) to Buy from Hold, with a price target of $92. The analyst is bullish on MTSI acquiring radio frequency business from Wolfspeed Inc (NYSE: WOLF) for $125 million. The...
-
FDA Greenlights Expanded Use Of Neurocrine Biosciences' Ingrezza: Analysts Weigh In Depression Warning
Monday, August 21, 2023 - 2:24pm | 549The FDA approved Neurocrine Biosciences Inc's (NASDAQ: NBIX) Ingrezza (valbenazine) capsules for the treatment of adults with chorea associated with Huntington's disease (HD). Ingrezza is the only selective vesicular monoamine transporter 2 (VMAT2) inhibitor that offers an...
-
This Healthcare Tech Company Has Become The First To Receive FDA De Novo Authorization For An OTC COVID-19 Test
Thursday, August 17, 2023 - 8:05am | 993The healthcare technology company Cue Health Inc. (NASDAQ: HLTH) has become the first company to get De Novo authorization from the U.S. Food and Drug Administration (FDA) for an over-the-counter COVID-19 test — as well as being the first FDA De Novo authorization for any over-the-counter...
-
Amazon To Rally Over 66%? Here Are 10 Other Analyst Forecasts For Friday
Friday, August 11, 2023 - 8:02am | 538Needham raised the price target for CyberArk Software Ltd. (NASDAQ: CYBR) from $185 to $190. Needham analyst Alex Henderson maintained a Buy rating. CyberArk Software shares fell 0.3% to $161.50 in pre-market trading. Stephens & Co. increased Carrols Restaurant Group, Inc. (NASDAQ: TAST)...
-
Gaia And 2 Other Stocks Under $4 Insiders Are Buying
Tuesday, August 8, 2023 - 8:50am | 519The Dow Jones closed lower by over 400 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision....
-
McKesson, Kinder Morgan And 2 Other Stocks Insiders Are Selling
Tuesday, August 8, 2023 - 8:20am | 641The Nasdaq 100 closed higher on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders sell shares, it could be a preplanned sale, or could indicate their concern in the company’s prospects or that they view the stock as being overpriced. Insider sales should not...
-
Wayfair To Rally Over 32%? Here Are 10 Other Analyst Forecasts For Monday
Monday, August 7, 2023 - 7:52am | 556Needham raised the price target for MACOM Technology Solutions Holdings, Inc. (NASDAQ: MTSI) from $65 to $84. Needham analyst Quinn Bolton maintained a Buy rating. MACOM Technology shares rose 0.1% to $170.70 in pre-market trading. RBC Capital cut Sage Therapeutics, Inc. (NASDAQ: SAGE) price...
-
Yum! Brands To Rally Around 20%? Here Are 10 Other Analyst Forecasts For Thursday
Thursday, August 3, 2023 - 8:06am | 539Needham raised the price target for Extreme Networks, Inc. (NASDAQ: EXTR) from $30 to $35. Needham analyst Alex Henderson maintained a Buy rating. Extreme Networks shares fell 1.7% to $29.70 in pre-market trading. Canaccord Genuity cut PayPal Holdings, Inc. (NASDAQ: PYPL) price target from $...
-
Fear & Greed Index Moves To 'Greed' Zone After S&P 500 Settles Lower
Wednesday, August 2, 2023 - 3:47am | 352U.S. stocks closed mixed on Tuesday, as investors digested recent earnings reports and a fresh batch of economic data. Merck & Co Inc (NYSE: MRK) posted a narrower-than-expected quarterly loss, while sales topped estimates. Pfizer Inc (NYSE: PFE) reported a second-quarter adjusted EPS of $0.67...
-
Masimo, Medical Device Maker Drops On Q2 Guidance, Opportunity?
Wednesday, July 26, 2023 - 11:53am | 693Shares of health monitoring technology maker Masimo Corporation (NASDAQ: MASI) dropped 24% to $114.30 last week due to a second-quarter performance warning. They are at their lowest level since January 2019 — but according to Wall Street, could have healthy gains ahead. The Irvine,...